Vessi Medical’s surface cryoablation therapy for bladder cancer demonstrates successful animal trial results

Vessi’s bladder-specific cryoablation technology may eliminate problems often reported with transurethral resection of bladder tumor (TURBT), today’s first line of treatment.

Leviticus Cardio Awarded R&D Grant from BIRD Foundation

Leviticus Cardio and Jarvik Heart were awarded an R&D grant from the prestigious Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.

NextInsight: Patients recovering well after scoliosis treatment with ApiFix

The procedures in Singapore with the ApiFix system “went exceptionally well and significant curve correction was achieved … .”

Successful first in human for ZygoFix’s spinal facet joint fixation system

ZygoFix announced the successful start of a first in human clinical study for its zLOCK spinal facet joint fixation system.

Leviticus Cardio announces success of six-month chronic animal study

Leviticus announced the successful completion of its groundbreaking 180-day preclinical study.

Trendlines report: 10 companies to watch Q3 2018

Here is our 10 Companies to Watch report for Q3 2018.

ApiFix surpasses 250 scoliosis patients and 6-year follow-up of earliest patients

ApiFix announced its technology has now been used to treat more than 250 young patients diagnosed with progressive scoliosis.

Leviticus Cardio announces successful completion of third chronic animal study

Leviticus Cardio successfully completed a 90-day chronic animal study to evaluate its Coplanar Energy Transfer (CET) technology in combination with a commercial heart pump.

ApiFix featured in Canadian media

ApiFix was featured in the Canadian media.

Trendlines report: 10 companies to watch Q2 2018

Here is our 10 Companies To Watch report for Q2 2018.